Laura A V Marlow1, Jo Waller, Jane Wardle. 1. Cancer Research UK Health Behaviour Unit, Department of Epidemiology and Public Health, UCL, Gower Street, 2-16 Torrington Place, London WC1E 6BT, United Kingdom.
Abstract
OBJECTIVES: To determine the acceptability of childhood HPV vaccination and examine demographic, cultural, and psychosocial predictors of vaccine acceptance. DESIGN: School-based survey. PARTICIPANTS: Questionnaires sent to 1205 mothers of 8-14-year-old girls. Responses from 684 were included in the analyses. SETTING: Ten schools (seven primary, three secondary) in four areas of England. RESULTS: Seventy-five percent of mothers would accept the vaccine for their daughter. Vaccine acceptance was higher in mothers who had experience of cancer in the family (OR=1.61, CI: 1.14-2.29), had older daughters (OR=1.15, CI: 1.04-1.27), perceived approval from husband/partner (OR=14.51, CI: 6.15-34.25) and believed vaccine acceptance would be more normative (OR=1.78, CI: 1.59-2.01). Having concerns about too many vaccinations (OR=0.22, CI: 0.15-0.31) or vaccine side effects (OR=0.37, CI: 0.28-0.50) and worry about increasing promiscuity (OR=0.47, CI: 0.36-0.62) emerged as deterrents. The modal preferred age was 12 years. Endorsing vaccination at earlier ages was predicted by feeling able to discuss related topics, including sex, at younger ages (OR=1.37, CI: 1.24-1.51) and concern about increasing promiscuity (OR=0.61, CI: 0.47-0.78). CONCLUSIONS: Overall, there was a favourable response to HPV vaccination. Emphasising the widespread acceptance of the vaccine might promote acceptance further, as would information on immunological and social benefits of earlier vaccination.
OBJECTIVES: To determine the acceptability of childhood HPV vaccination and examine demographic, cultural, and psychosocial predictors of vaccine acceptance. DESIGN: School-based survey. PARTICIPANTS: Questionnaires sent to 1205 mothers of 8-14-year-old girls. Responses from 684 were included in the analyses. SETTING: Ten schools (seven primary, three secondary) in four areas of England. RESULTS: Seventy-five percent of mothers would accept the vaccine for their daughter. Vaccine acceptance was higher in mothers who had experience of cancer in the family (OR=1.61, CI: 1.14-2.29), had older daughters (OR=1.15, CI: 1.04-1.27), perceived approval from husband/partner (OR=14.51, CI: 6.15-34.25) and believed vaccine acceptance would be more normative (OR=1.78, CI: 1.59-2.01). Having concerns about too many vaccinations (OR=0.22, CI: 0.15-0.31) or vaccine side effects (OR=0.37, CI: 0.28-0.50) and worry about increasing promiscuity (OR=0.47, CI: 0.36-0.62) emerged as deterrents. The modal preferred age was 12 years. Endorsing vaccination at earlier ages was predicted by feeling able to discuss related topics, including sex, at younger ages (OR=1.37, CI: 1.24-1.51) and concern about increasing promiscuity (OR=0.61, CI: 0.47-0.78). CONCLUSIONS: Overall, there was a favourable response to HPV vaccination. Emphasising the widespread acceptance of the vaccine might promote acceptance further, as would information on immunological and social benefits of earlier vaccination.
Authors: Alexander G Fiks; Robert W Grundmeier; Stephanie Mayne; Lihai Song; Kristen Feemster; Dean Karavite; Cayce C Hughes; James Massey; Ron Keren; Louis M Bell; Richard Wasserman; A Russell Localio Journal: Pediatrics Date: 2013-05-06 Impact factor: 7.124
Authors: Maureen Sanderson; Ann L Coker; Katherine S Eggleston; Maria E Fernandez; Concepcion D Arrastia; Mary K Fadden Journal: J Womens Health (Larchmt) Date: 2009-11 Impact factor: 2.681
Authors: Rebecca Stretch; Rosemary McCann; Stephen A Roberts; Peter Elton; David Baxter; Loretta Brabin Journal: BMC Public Health Date: 2009-07-21 Impact factor: 3.295